- Home
- About Us
-
Oncology
- BLADDER CANCER
- BRAIN TUMOR
-
BREAST CANCER
- Afinitor (Everolimus)
- Afinitor Disperz (everolimus)
- AROMASIN (exemestane) tablets
- ELLENCE (epirubicin hydrochloride)
- ENHERTU (trastuzumab-deruxtecan)
- FEMARA (letrozole)
- Ibrance (Palbociclib
- IXEMPRA (ixabepilone)
- KISQALI (Ribociclib)
- NERLYNX (Neratinib)
- NOLVADEX (tamoxifen citrate)
- ONTRUZANT (trastuzumab-dttb)
- PIQRAY (alpelisib)
- KADCYLA (ado-trastuzumab emtansine)
- LYNPARZA (olaparib)
- PALBACE (Palbociclib)
- PERJETA (Pertuzumab)
- PALBOCICLIB
- RIBOCICLIB
- PHESGO (pertuzumab-trastuzumab-hyaluronidase-zzxf)
- Talzenna (Talazoparib)
- TRAZIMERA (trastuzumab-qyyp)
- TRODELVY (Sacituzumab govitecan-hziy)
- TUKYSA (Tucatinib)
- TAXOTERE (Docetaxel)
- TYKERB (lapatinib)
- VIJOICE (alpelisib)
- ZINECARD (dexrazoxane)
- CERVICAL CANCER
- KIDNEY DISEASE
-
LUNG CANCER
- AVASTIN (bevacizumab)
- ALECENSA (Alectinib)
- ALIMTA (Pemetrexed)
- ALUNBRIG (Brigatinib)
- CRIZALK (Crizotinib)
- CYENDIV (nintedanib)
- ERLONAT (Erlotinib)
- GEFTINAT (Gefitinib)
- GILOTRIF (Afatinib)
- DACOPLICE (dacomitinib)
- HYCAMTIN (Topotecan)
- IRESSA Gefitinib
- IMFINZI (Durvalumab)
- LORBRENA (lorlatinib)
- LUMAKRAS (SOTORASIB)
- MEKINIST (Trametinib)
- NINTENA (Nintedanib)
- OFEV (Nintedanib)
- ORKAMBI (Lumacaftor/Ivacaftor)
- PORTRAZZA (Necitumumab)
- PEMNAT (Pemetrexed)
- ROZLYTREk (Entrectinib)
- TABRECTA (Capmatinib)
- TAGRISSO (Osimertinib)
- TECENTRIQ
- TRIKAFTA (elexacaftor/tezacaftor/ivacaftor)
- VARGATEF (Nintedanib)
- VIZIMPRO (Dacomitinib)
- XALKORI (crizotinib)
- THYROID CANCER
- SOFT TISSUE SARCOMA
-
Harmatology
-
BLOOD DISORDERS
- ANDEXXA (coagulation factor Xa (recombinant)
- ARANESP (darbepoetin alfa)
- EXJADE (deferasirox)
- ENJAYMO (sutimlimab-jome)
- Human Albumin Baxalta
- INREBIC (fedratinib)
- NYVEPRIA (pegfilgrastim-apgf)
- RETACRIT (epoetin alfa-epbx)
- SOTYKTU (deucravacitinib)
- SPEVIGO (spesolimab-sbzo)
- THALIX Thalidomide
- ULTOMIRIS (ravulizumab-cwvz)
- VONJO (pacritinib)
- BONE MARROW
- DERMATOLOGY
-
LEUKEMIA
- ADAKVEO (crizanlizumab-tmca) injection
- ATRIANCE (Nelarabine)
- Arzerra (Ofatumumab)
- BESPONSA (Inotuzumab ozogamicin)
- BLINCYTO (Blinatumomab)
- BOSULIF (Bosutinib)
- ERWINASE (Asparaginase)
- GLEEVEC (Imatinib)
- GLIVEC (Imatinib)
- VEENAT (Imatinib Mesylate)
- KYMRIAH (tisagenlecleucel)
- Idamycin idarubicin
- MAB CAMPATH (Alemtuzumab)
- MYLOTARG (gemtuzumab ozogamicin)
- NEUPOGEN (Filgrastim)
- NIVESTYM (filgrastim-aafi)
- ONCASPAR (Pegaspargase)
- ONUREG (azacitidine)
- PROMACTA (eltrombopag)
- RYDAPT (Midostaurin)
- SYNRIBO (Omacetaxine mepesuccinate)
- SCEMBLIX (asciminib) tablets
- TASIGNA (Nilotinib)
- Tibsovo (ivosidenib)
- VENCLEXTA (Venetoclax)
- VYXEOS (Daunorubicin and Cytarabine)
- XOSPATA (Gilteritinib)
- ZYDELIG (Idelalisib)
- LYMPHOMA
-
MELANOMA
- AGRYLIN (Anagrelide)
- DEFITELIO (Difibrotide)
- ELDISINE (Vindesine Sulphate)
- JAKAFI (Ruxolitinib)
- KIMMTRAK (tebentafusp-tebn)
- LIBTAYO (cemiplimab-rwlc)
- NPLATE (Romiplostim)
- MEKTOVI (binimetinib)
- Opdualag Nivolumab (relatlimab-rmbw)
- SARCLISA (isatuximab-irfc)
- TEPADINA (Thiotepa)
- TAFINLAR (dabrafenib)
- ZELBORAF (Vemurafenib)
- MULTIPLE MYELOMA
-
BLOOD DISORDERS
- Gastroenterology
- Influenza
-
Other Drugs
-
MISCELLANEOUS
- ADUCANUMAB
- OBETICHOLIC ACID
- ZOLEDRONATE
- BOTOX (Botulinum toxin)
- VIAGRA (Sildenafil)
- KAMAGRA GOLD (Sildenafil Citrate)
- SUHAGRA (Sildenafil Citrate)
- TADACIP (Tadalafil)
- eptinezumab-jjmr
- Cabotegravir/rilpivirine
- CYMEVENE (Ganciclovir)
- Eptinezumab-JJMR
- EMGALITY (Galcanezumab-gnlm)
- GUTRON (midodrine)
- Dextromethorphan / Bupropion
- ILARIS (canakinumab)
- KANUMA (sebelipase-alfa)
- Osilodrostat
- Rimegepant
- SOLIRIS eculizumabeculizumab)
- SOMAVERT (pegvisomant)
- Ubrogepant
- VISTIDE (Cidofovir)
- Vitrakvi (larotrectinib)
- XADAGO (safinamide)
- XERMELO (telotristat ethyl)
- ZOSTAVAX (zoster vaccine live)
- ZOLGENSMA (Onasemnogene abeparvovec-xioi)
- ASTHAMA
- CARDIOLOGY
- CROHN'S DISEASE
- DIARRHEA
- EYE
- FUNGAL DISEASE
- IMMUNE SYSTEM
- NEURO
- TRANSPLANT
- RHEUMATOID ARTHRITIS
- SPINE
- MULTIPLE SCLEROSIS
- TRANSPLANT MEDICATION
- HIV MEDICINES
- WEIGHT MANAGEMENT
-
MISCELLANEOUS
- FAQ
- Updates
- Contact Us
Indian Pharma Network
For Urgent Support
24/7 Free Support
Call US
+91 9891296838 / 9811747774
Antifungal Medication
If you have an enquiry about the FDA approved anti-cancer drugs / medicines approved by the Food and Drug Administration (FDA) for Anti Fungal treatment. To get access in India or overseas please call M: +91 9891296838 / 9811747774 at India Standard Time (IST) or email us in details about your requirement at info@indianpharmanetwork.co.in. Our customer support team always ready to help you, they will support you 24/7.
Get In Touch
- Mobile: +91-9891296838 / 9811747774
- WhatsApp: +91-9891296838
- Email: info@indianpharmanetwork.co.in
- Social Media:
Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016
Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398
Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in